高级搜索

消癌平抗鼠H22肝细胞癌生长和血管生成的实验

赵和平, 平梅

赵和平, 平梅. 消癌平抗鼠H22肝细胞癌生长和血管生成的实验[J]. 肿瘤防治研究, 2012, 39(05): 497-501. DOI: 10.3971/j.issn.1000-8578.2012.05.002
引用本文: 赵和平, 平梅. 消癌平抗鼠H22肝细胞癌生长和血管生成的实验[J]. 肿瘤防治研究, 2012, 39(05): 497-501. DOI: 10.3971/j.issn.1000-8578.2012.05.002
Zhao Heping, Ping Mei. Effect of Xiaoaiping on Growth and Angiogenesis of H22 Hepatic Carcinoma in Mice[J]. Cancer Research on Prevention and Treatment, 2012, 39(05): 497-501. DOI: 10.3971/j.issn.1000-8578.2012.05.002
Citation: Zhao Heping, Ping Mei. Effect of Xiaoaiping on Growth and Angiogenesis of H22 Hepatic Carcinoma in Mice[J]. Cancer Research on Prevention and Treatment, 2012, 39(05): 497-501. DOI: 10.3971/j.issn.1000-8578.2012.05.002

消癌平抗鼠H22肝细胞癌生长和血管生成的实验

详细信息
    作者简介:

    赵和平(1954-),男,本科,教授,主要从事消化道肿瘤的研究

  • 中图分类号: R735.7

Effect of Xiaoaiping on Growth and Angiogenesis of H22 Hepatic Carcinoma in Mice

  • 摘要: 目的 通过观察不同浓度消癌平(XAP)对小鼠移植瘤血管生成的影响,探讨XAP抑制肝细胞癌生长可能的作用机制。方法 昆明小鼠75只,接种H22肝癌细胞。随机分为D1、D2、X1、X2、X3组,其中D1、D2组分别腹腔注射5-氟尿嘧啶(5-Fu)、0.9%氯化钠溶液做为阳性、阴性对照,X1、X2、X3组分别给予10 g/(kg·d)、20 g/(kg·d)、40 g/(kg·d)的XAP腹腔注射。计算各瘤体体积,绘制肿瘤生长曲线;用药3周后剥离瘤体,称量,计算抑瘤率;光学显微镜下观察组织病理变化;免疫组织化学法检测瘤组织中CD34所标记的微血管密度;酶联免疫吸附实验(ELISA)检测血清中血管内皮生长因子(VEGF)含量。结果X3组与D1组抑瘤率相近(P>0.05);X1、X2、X3组血清VEGF均低于D2组(P<0.05),其中X3组降低最为明显;MVD也得到同样的结果。结论不同剂量的XAP均可抑制H22肝癌小鼠移植瘤的生长,且40 g/(kg·d)抑制作用最佳。XAP可能是通过抑制VEGF的生成,从而降低肿瘤组织中MVD,使得局部肿瘤组织缺血、坏死,进而抑制肿瘤的生长。

     

    Abstract: Objective To study the effects of Xiaoaiping(XAP) with different concentrations on the tumor angiogenesis in mice and to discuss its possible mechanism in the inhibition of hepatic cellular cancer growth. Methods Seventy-five female KM mice whose weight is about(20±2)g were injected H22 liver tumor cells.They were randomly divided into five groups as following:D1(5-fluorouracil(5-Fu) was peritoneal injected,as a positive control),D2(NS was peritoneal injected,as a negative control),groups X1,X2 and X3 were peritoneal injected with XAP of 10 g/(kg·d),20 g/(kg·d) and 40 g/(kg ·d) respectively.The tumor′s volume was calculated to draw the tumor growth curve.The tissue of xenografted tumors was taken after 3 week′s treatment.The xenografted tumors were weighted its inhibitory rate was calculated.The pathological changes were observed by light microscope.The microvessel density(MVD) marked by CD34 in the xenografted tumor tissue was detected by immunohistochemisty.The concentration of serum VEGF was measured by ELISA. Results The inhibition rate in X3 and D1 group was similar(P>0.05).The doses of serum VEGF in X1,X2 and X3 group were all lower than that in D2 group(P<0.05),especially in X3group.To detect MVD,the conditions were the same as the dose of serum VEGF. Conclusion Different doses of XAP can inhibit tumor growth of H22 liver cancer in mice and the medium dose of XAP has the best inhibition.XAP may reduce VEGF and decrease MVD in tumor to make tumor ischemia and necrosis in order to inhibit tumor growth.

     

  • [1] Parkin DM,Bray F,Ferlay J,et al.Estimating the world cancer burden:Globocan 2000[J].Int JCancer,2001,94(2):153-6.
    [2] Tang ZY.Hepatocellular carcinoma surgery-review of the past and prospects for the 21st century[J].J Surg Oncol,2005,91(2):95-6.
    [3] Zhang XY,Zhang H,Zhai YJ.Studies on two compounds from marsdenia tenacissima[J].LiaoningZhong Yi Yao Da Xue Xue Bao,2007,9(2):130.[张雪莹,张慧,翟延君.通关藤两个化合物的研究[J].辽宁中医药大学学报,2007,9(2):130.]
    [4] Li D,Ouyang J,Li CP,et al.Preliminary study of the effects of Xiaoaiping injection on NB4 cells[J].Zhongguo Sheng Hua Yao Wu Za Zhi,2007,28(4):247-50.[李东,欧阳建,李翠萍,等.消癌平注射液对白血病细胞NB4作用的初步研究[J].中国生化药物杂志,2007,28(4):247-50.]
    [5] Chen TS,Wang LX,Wang HY.Timely monitoring of the activation of Xiaoaping-induced cysteineaspartase 3 in human lung adenocarcinoma cells by fluorescence resonance energy transfer technology[J].Zhongguo Zu Zhi Gong Cheng Yan Jiu Yu Lin Chuang Kang Fu,2007,11(35):7102-5.[陈同生,王龙祥,王会营.荧光共振能量转移技术对肺腺癌活细胞中消癌平诱导半胱氨酸天冬氨酸酶3活化过程的实时监测[J].中国组织工程研究与临床康复,2007,11(35):7102-5.]
    [6] Li H,Ye Q,Yin XJ,et al.The research of angiogenesis in hepatocellular carcinoma[J].Lin ChuangZhong Liu Xue Za Zhi,2009,14(4):369-72.[李惠,叶庆,殷晓进,等.肝细胞肝癌血管新生的研究进展[J].临床肿瘤学杂志,2009,14(4):369-72.]
    [7] Ozel L,Ozel MS,Toros AB,et al.Effect of early preoperative 5-fluorouracil on the integrity ofcolonic anastomoses in rats[J].World J Gastroenterol,2009,15(33):4156-62.
    [8] CrossMJ,Claesson-Welsh L.FGF and VEGF function in angiogenesis:signalling pathways,biologicalresponses and therapeutic inhibition[J].Trends Pharmacol Sci,2001,22(4):201-7.
    [9] Lin EY,Li JF,Bricard G,et al.Vascular endothelial growth factor restores delayed tumorprogression in tumors depleted of macrophages[J].Mol Oncol,2007,1(3):288-302.
    [10] Shibuya M.Vascular endothelial growth factor-dependent and independent regulation ofangiogenesis[J].BMB Rep,2008,41(4):278-86.
    [11] Li M,Yao DF,Dong ZZ,et al.Clinical values of quantitative analysis of vascular endothelialgrowth factor expression of tissues and sera in hepatocellular carcinoma[J].Tianjin YiYao,2009,37(2):88-90.[李敏,姚登福,董志珍,等.人肝癌组织及外周血VEGF表达水平定量分析的临床价值[J].天津医药,2009,37(2):88-90.]
    [12] Li ZW,Lu GE,Hu AG,et al.Relationship between VEGF expression,rumor angiogenesis andinvasion,metastasis and prognosis of hepatocellular carcinoma[J].Zhongguo Xian Dai Yi Xue Za Zhi,2003,13(16):15-7.[李志伟,鲁广恩,胡安国,等.VEGF表达及MVD与肝细胞癌侵袭、转移和预后的关系[J].中国现代医学杂志,2003,13(16):15-7.]
    [13] Meng SK,Wu CX.Research of the abstract and in vitro anti-tumor of a new glycoside B frommarsdenia tenacissima[J].Hai Xia Yao Xue,2009,21(11):34-7.[孟昭珂,吴春霞.通关藤新甙B的提取及体外抗肿瘤活性研究[J].海峡药学,2009,21(11):34-7.]
计量
  • 文章访问数:  2556
  • HTML全文浏览量:  18
  • PDF下载量:  648
  • 被引次数: 0
出版历程
  • 收稿日期:  2011-11-06
  • 修回日期:  2012-02-12
  • 刊出日期:  2012-05-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭